Bone and Mineral Metabolism Disorders News

Managing the cascade of illness triggered by the imbalance of calcium and phosphorus challenges physicians who care for patients with CKD.

Solid organ transplant recipients who develop hyperkalemia have an increased risk of mortality and 30-day readmissions, according to results presented at ASN Kidney Week 2018.

A recently published study shows use of patiromer in a large, hemodialysis patient population proved effective in reducing hyperkalemia.

SAN DIEGO — In this exclusive video from ASN Kidney Week 2018, Ian Sabir, June Zhao, MD, PhD and Ayman Al-Shurbaji, MD, PhD, discuss a phase III study that compared 5 g and 10 g of Lokelma (sodium zirconium cyclosilicate, AstraZeneca) with placebo for the treatment of hyperkalemia.

SAN DIEGO — At ASN Kidney Week 2018, Annamaria T. Kausz, MD, MS, discussed two phase III trials that evaluated the safety and efficacy of ALLN-177 in patients with enteric hyperoxaluria.

SAN DIEGO — At the ASN Kidney Week 2018, Sagar U. Nigwekar, MD, MMSc, spoke about the clinical characteristics and kidney stone burden in patients with enteric hyperoxaluria in three phase II studies that evaluated the use of ALLN-177.

SAN DIEGO —Patients on hemodialysis who have a high risk of vascular calcification show no difference in cardiovascular risk if they receive the non-calcium binder lanthanum carbonate or the calcium carbonate binder, according to data presented at ASN Kidney Week. The results were part of the multicenter LANDMARK study, a randomized, open-label trial comparing the effects of lanthanum carbonate with the effects of calcium carbonate.

Use of proton pump inhibitors may increase risk of hip fracture in patients with ESKD on hemodialysis, according to a recently published study.

Rockwell Medical Inc. reported that it has received FDA approval to begin manufacturing Calcitriol, the company’s active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.

Changes made in the Medicare payment methodology for dialysis care in 2011 that bundled prescription drugs and treatment payment resulted in both a drop in initiation and in the dosage of vitamin D, according to a recently published study.